ArticleAntibody therapeutics2022

Pan-cancer distribution of cleaved cell-surface amphiregulin, the target of the GMF-1A3 antibody drug conjugate.

Kristopher A Lofgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.